menu
    • menu

    Company profile for Lexaria Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs. Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically...
    Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs. Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically-administered products, including patches, creams and lotions. Lexaria’s technology is currently being evaluated for improved delivery characteristics of antiviral drugs in the global fight against COVID-19.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lexaria BioscienceCanada Flag
    Country
    Country
    Canada
    Address
    Address
    #100-740 McCurdy Rd Kelowna, BC V1X2P7
    Telephone
    Telephone
    250-765-6424
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexariabioscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lexaria-bioscience/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/LexariaBioCorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexaria's Registered GLP-1 Study #4 Begins Dosing
    Lexaria's Registered GLP-1 Study #4 Begins Dosing

    19 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/957184/lexarias-registered-glp-1-study-4-begins-dosing

    ACCESSWIRE
    19 Dec 2024
    Share Share
    Harvard’s Dr. Michael Appointed Chief Medical Advisor at Lexaria
    Harvard’s Dr. Michael Appointed Chief Medical Advisor at Lexaria

    17 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/956013/esteemed-harvard-medical-school-professor-dr-michael-gibson-appointed-chief-medical-advisor-at-lexaria-bioscience

    ACCESSWIRE
    17 Dec 2024
    Share Share
    Liraglutide Processed with DehydraTECH in Human Study #5
    Liraglutide Processed with DehydraTECH in Human Study #5

    09 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/951505/liraglutide-processed-with-dehydratech-to-be-studied-in-human-glp-1-study-5

    ACCESSWIRE
    09 Dec 2024
    Share Share
    Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs
    Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

    26 Nov 2024

    // ACCESSWIRE

    https://www.accesswire.com/947132/revolutionizing-healthcare-lexaria-highlights-expanding-therapeutic-benefits-of-glp-1-drugs

    ACCESSWIRE
    26 Nov 2024
    Share Share
    Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
    Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

    25 Nov 2024

    // ACCESSWIRE

    https://www.accesswire.com/946575/lexarias-glp-1-human-pilot-study-3-completes-dosing-as-scheduled

    ACCESSWIRE
    25 Nov 2024
    Share Share
    All Groups Outperform Rybelsus® in Diabetes Weight Control Study
    All Groups Outperform Rybelsus® in Diabetes Weight Control Study

    20 Nov 2024

    // ACCESSWIRE

    https://www.accesswire.com/944817/all-study-groups-using-dehydratech-processing-outperform-rybelsus-in-body-weight-control-in-lexarias-12-week-glp-1-diabetes-animal-study

    ACCESSWIRE
    20 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search